Two vaccines (Rotarix and RotaTeq), administered orally, have marketing authorization in France. A vaccination is recommended with two doses at the ages of two and three months for Rotarix, with three doses at two, three and four months for RotaTeq, she specifies in a press release, inviting the use of the same vaccine for the whole scheme. vaccine.
The HAS insists on respecting this schedule in order to be able to complete the vaccination schedule before the age limit (six months for Rotarix and eight months for RotaTeq). “At this stage, the HAS considers that it is premature to envisage making this vaccination compulsory,” she specifies.
“Very good efficacy of the two vaccines”
Recommended by the World Health Organization, the European Academy of Pediatrics and the European Society for Pediatric Infectious Diseases, vaccination against rotavirus infections is practiced in 127 countries worldwide. Introduced in France in the vaccination calendar in 2013 by the High Council of Public Health, it was suspended in 2015 after the occurrence of serious adverse effects.
After reassessing the two available vaccines and reviewing the latest vaccine efficacy and tolerance data, HAS judges that they confirm “very good efficacy of these two vaccines” in preventing these infections but also serious forms of gastroenteritis, which can lead to a visit to the emergency room and/or hospitalization.